Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Bedaquiline-resistant Tuberculosis: Dark Clouds on the Horizon.

Andres S, Merker M, Heyckendorf J, Kalsdorf B, Rumetshofer R, Indra A, Hofmann-Thiel S, Hoffmann H, Lange C, Niemann S, Maurer FP.

Am J Respir Crit Care Med. 2020 Feb 13. doi: 10.1164/rccm.201909-1819LE. [Epub ahead of print] No abstract available.

PMID:
32053752
2.

International Society of Cardiovascular Infectious Diseases Guidelines for the Diagnosis, Treatment and Prevention of Disseminated Mycobacterium chimaera Infection Following Cardiac Surgery with Cardiopulmonary Bypass.

Hasse B, Hannan MM, Keller PM, Maurer FP, Sommerstein R, Mertz D, Wagner D, Fernández-Hidalgo N, Nomura J, Manfrin V, Bettex D, Hernandez Conte A, Durante-Mangoni E, Tang TH, Stuart RL, Lundgren J, Gordon S, Jarashow MC, Schreiber PW, Niemann S, Kohl TA, Daley CL, Stewardson AJ, Whitener CJ, Perkins K, Plachouras D, Lamagni T, Chand M, Freiberger T, Zweifel S, Sander P, Schulthess B, Scriven JE, Sax H, van Ingen J, Mestres CA, Diekema D, Brown-Elliott BA, Wallace RJ Jr, Baddour LM, Miro JM, Hoen B; M. chimaera ISCVID Investigators and; ISCVID Executive Committee, Athan E, Bayer A, Barsic B, Corey GR, Chu VH, Durack DT, Fortes CQ, Fowler V, Hoen B, Krachmer AW, Durante-Magnoni E, Miro JM, Wilson WR; Infectious Diseases Specialists; Hospital Epidemiologists; Microbiologists and Molecular Typing Specialists; Cardiac Surgeons/ Perfusionists/ Cardiologists; Ophthalmology; Anaesthesiologists; Public Health.

J Hosp Infect. 2020 Feb;104(2):214-235. doi: 10.1016/j.jhin.2019.10.009. Epub 2019 Nov 9.

3.

[Tuberculosis].

Lange C, Kalsdorf B, Maurer FP, Heyckendorf J.

Internist (Berl). 2019 Nov;60(11):1155-1175. doi: 10.1007/s00108-019-00685-z. German.

PMID:
31641790
4.

A piperidinol-containing molecule is active against Mycobacterium tuberculosis by inhibiting the mycolic acid flippase activity of MmpL3.

Dupont C, Chen Y, Xu Z, Roquet-Banères F, Blaise M, Witt AK, Dubar F, Biot C, Guérardel Y, Maurer FP, Chng SS, Kremer L.

J Biol Chem. 2019 Nov 15;294(46):17512-17523. doi: 10.1074/jbc.RA119.010135. Epub 2019 Sep 27.

PMID:
31562241
5.

The landscape of diagnostic mycobacteriology in Germany-challenges of decentralised care.

Maurer FP, Mintken E, Rupp J, Olaru I, Kranzer K.

Int J Tuberc Lung Dis. 2019 Aug 1;23(8):913-918. doi: 10.5588/ijtld.18.0763.

PMID:
31533881
6.

Accuracy of whole-genome sequencing to determine recent tuberculosis transmission: an 11-year population-based study in Hamburg, Germany.

Diel R, Kohl TA, Maurer FP, Merker M, Meywald Walter K, Hannemann J, Nienhaus A, Supply P, Niemann S.

Eur Respir J. 2019 Nov 28;54(5). pii: 1901154. doi: 10.1183/13993003.01154-2019. Print 2019 Nov. No abstract available.

7.

Same meat, different gravy: ignore the new names of mycobacteria.

Tortoli E, Brown-Elliott BA, Chalmers JD, Cirillo DM, Daley CL, Emler S, Floto RA, Garcia MJ, Hoefsloot W, Koh WJ, Lange C, Loebinger M, Maurer FP, Morimoto K, Niemann S, Richter E, Turenne CY, Vasireddy R, Vasireddy S, Wagner D, Wallace RJ Jr, Wengenack N, van Ingen J.

Eur Respir J. 2019 Jul 11;54(1). pii: 1900795. doi: 10.1183/13993003.00795-2019. Print 2019 Jul. No abstract available.

PMID:
31296783
8.

Rifamycin derivatives active against pathogenic rapidly-growing mycobacteria.

Combrink KD, Ramos AR, Spring S, Schmidl S, Elizondo K, Morin P, De Jesus B, Maurer FP.

Bioorg Med Chem Lett. 2019 Aug 15;29(16):2112-2115. doi: 10.1016/j.bmcl.2019.07.001. Epub 2019 Jul 2.

PMID:
31281018
9.

Influence of local epidemiology on the performance of common colistin drug susceptibility testing methods.

Asar L, Pfefferle S, Lütgehetmann M, Hoffmann A, Katchanov J, Aepfelbacher M, Rohde H, Maurer FP.

PLoS One. 2019 Jun 6;14(6):e0217468. doi: 10.1371/journal.pone.0217468. eCollection 2019.

10.

[Joint Statement on the New WHO Recommendations for Treatment of Multidrug- and Rifampicin-Resistant Tuberculosis].

Maurer FP, Bauer T, Diel R, Häcker B, Lange C, Niemann S, Otto-Knapp R, Schönfeld N.

Pneumologie. 2019 May;73(5):270-273. doi: 10.1055/a-0880-9987. Epub 2019 May 13. German. No abstract available.

PMID:
31083750
11.

New World Health Organization Treatment Recommendations for Multidrug-Resistant Tuberculosis: Are We Well Enough Prepared?

Kranzer K, Kalsdorf B, Heyckendorf J, Andres S, Merker M, Hofmann-Thiel S, Bloemberg GV, Hoffmann H, Niemann S, Lange C, Maurer FP.

Am J Respir Crit Care Med. 2019 Aug 15;200(4):514-515. doi: 10.1164/rccm.201902-0260LE. No abstract available.

PMID:
31026398
12.

'Those who cannot remember the past are condemned to repeat it': Drug-susceptibility testing for bedaquiline and delamanid.

Köser CU, Maurer FP, Kranzer K.

Int J Infect Dis. 2019 Mar;80S:S32-S35. doi: 10.1016/j.ijid.2019.02.027. Epub 2019 Feb 25.

13.

Standards for MIC testing that apply to the majority of bacterial pathogens should also be enforced for Mycobacterium tuberculosis complex.

Schön T, Matuschek E, Mohamed S, Utukuri M, Heysell S, Alffenaar JW, Shin S, Martinez E, Sintchenko V, Maurer FP, Keller PM, Kahlmeter G, Köser CU.

Clin Microbiol Infect. 2019 Apr;25(4):403-405. doi: 10.1016/j.cmi.2019.01.019. Epub 2019 Feb 14. No abstract available.

PMID:
30771527
14.

Novel external quality assurance scheme for drug susceptibility testing of non-tuberculous mycobacteria: a multicentre pilot study.

Nikolayevskyy V, Maurer FP, Holicka Y, Taylor L, Liddy H, Kranzer K.

J Antimicrob Chemother. 2019 May 1;74(5):1288-1294. doi: 10.1093/jac/dkz027.

PMID:
30753511
15.

Differential drug susceptibility patterns of Mycobacterium chimaera and other members of the Mycobacterium avium-intracellulare complex.

Maurer FP, Pohle P, Kernbach M, Sievert D, Hillemann D, Rupp J, Hombach M, Kranzer K.

Clin Microbiol Infect. 2019 Mar;25(3):379.e1-379.e7. doi: 10.1016/j.cmi.2018.06.010. Epub 2018 Jun 12.

PMID:
29906595
16.

Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations.

Katchanov J, Asar L, Klupp EM, Both A, Rothe C, König C, Rohde H, Kluge S, Maurer FP.

PLoS One. 2018 Apr 12;13(4):e0195757. doi: 10.1371/journal.pone.0195757. eCollection 2018.

17.

ESGAP inventory of target indicators assessing antibiotic prescriptions: a cross-sectional survey.

Howard P, Huttner B, Beovic B, Beraud G, Kofteridis DP, Pano Pardo J, Schouten J, Pulcini C; ESGAP Indicators Working Group.

J Antimicrob Chemother. 2017 Oct 1;72(10):2910-2914. doi: 10.1093/jac/dkx243.

PMID:
29091207
18.

Emergence of ceftazidime/avibactam non-susceptibility in an MDR Klebsiella pneumoniae isolate.

Both A, Büttner H, Huang J, Perbandt M, Belmar Campos C, Christner M, Maurer FP, Kluge S, König C, Aepfelbacher M, Wichmann D, Rohde H.

J Antimicrob Chemother. 2017 Sep 1;72(9):2483-2488. doi: 10.1093/jac/dkx179.

PMID:
28637339
19.

Advances in Rapid Identification and Susceptibility Testing of Bacteria in the Clinical Microbiology Laboratory: Implications for Patient Care and Antimicrobial Stewardship Programs.

Maurer FP, Christner M, Hentschke M, Rohde H.

Infect Dis Rep. 2017 Mar 30;9(1):6839. doi: 10.4081/idr.2017.6839. eCollection 2017 Mar 30. Review.

20.

[Advances in diagnostic microbiology : Opportunities and limitations].

Maurer FP, Hentschke M, Rohde H.

Med Klin Intensivmed Notfmed. 2017 Apr;112(3):199-205. doi: 10.1007/s00063-017-0275-z. Epub 2017 Mar 24. Review. German.

PMID:
28342095
21.

Risk factors for excessively prolonged meropenem use in the intensive care setting: a case-contol study.

Katchanov J, Kreuels B, Maurer FP, Wöstmann K, Jochum J, König C, Seoudy K, Rohde H, Lohse AW, Wichmann D, Baehr M, Rothe C, Kluge S.

BMC Infect Dis. 2017 Feb 8;17(1):131. doi: 10.1186/s12879-017-2229-8.

22.

The Technical and Biological Reproducibility of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) Based Typing: Employment of Bioinformatics in a Multicenter Study.

Oberle M, Wohlwend N, Jonas D, Maurer FP, Jost G, Tschudin-Sutter S, Vranckx K, Egli A.

PLoS One. 2016 Oct 31;11(10):e0164260. doi: 10.1371/journal.pone.0164260. eCollection 2016.

23.

Standardization of Operator-Dependent Variables Affecting Precision and Accuracy of the Disk Diffusion Method for Antibiotic Susceptibility Testing.

Hombach M, Maurer FP, Pfiffner T, Böttger EC, Furrer R.

J Clin Microbiol. 2015 Dec;53(12):3864-9. doi: 10.1128/JCM.02351-15. Epub 2015 Oct 14.

24.

Relative contribution of biological variation and technical variables to zone diameter variations of disc diffusion susceptibility testing.

Hombach M, Ochoa C, Maurer FP, Pfiffner T, Böttger EC, Furrer R.

J Antimicrob Chemother. 2016 Jan;71(1):141-51. doi: 10.1093/jac/dkv309. Epub 2015 Oct 12.

PMID:
26462987
25.

The Resistant-Population Cutoff (RCOFF): a New Concept for Improved Characterization of Antimicrobial Susceptibility Patterns of Non-Wild-Type Bacterial Populations.

Valsesia G, Hombach M, Maurer FP, Courvalin P, Roos M, Böttger EC.

J Clin Microbiol. 2015 Jun;53(6):1806-11. doi: 10.1128/JCM.03505-14. Epub 2015 Mar 11.

26.

Aminoglycoside-modifying enzymes determine the innate susceptibility to aminoglycoside antibiotics in rapidly growing mycobacteria.

Maurer FP, Bruderer VL, Castelberg C, Ritter C, Scherbakov D, Bloemberg GV, Böttger EC.

J Antimicrob Chemother. 2015 May;70(5):1412-9. doi: 10.1093/jac/dku550. Epub 2015 Jan 20.

27.

Evaluation of carbapenemase screening and confirmation tests with Enterobacteriaceae and development of a practical diagnostic algorithm.

Maurer FP, Castelberg C, Quiblier C, Bloemberg GV, Hombach M.

J Clin Microbiol. 2015 Jan;53(1):95-104. doi: 10.1128/JCM.01692-14. Epub 2014 Oct 29.

28.

Postsurgical wound infections due to rapidly growing mycobacteria in Swiss medical tourists following cosmetic surgery in Latin America between 2012 and 2014.

Maurer F, Castelberg C, von Braun A, Wolfensberger A, Bloemberg G, Bottger E, Somoskovi A.

Euro Surveill. 2014 Sep 18;19(37). pii: 20905. No abstract available.

29.

Survey of macrolide-resistant Mycoplasma pneumoniae in children with community-acquired pneumonia in Switzerland.

Meyer Sauteur PM, Bleisch B, Voit A, Maurer FP, Relly C, Berger C, Nadal D, Bloemberg GV.

Swiss Med Wkly. 2014 Sep 25;144:w14041. doi: 10.4414/smw.2014.14041. eCollection 2014. No abstract available.

30.

Integrating forecast probabilities in antibiograms: a way to guide antimicrobial prescriptions more reliably?

Maurer FP, Courvalin P, Böttger EC, Hombach M.

J Clin Microbiol. 2014 Oct;52(10):3674-84. doi: 10.1128/JCM.01645-14. Epub 2014 Aug 6.

31.

Lack of antimicrobial bactericidal activity in Mycobacterium abscessus.

Maurer FP, Bruderer VL, Ritter C, Castelberg C, Bloemberg GV, Böttger EC.

Antimicrob Agents Chemother. 2014 Jul;58(7):3828-36. doi: 10.1128/AAC.02448-14. Epub 2014 Apr 21.

32.

Erm(41)-dependent inducible resistance to azithromycin and clarithromycin in clinical isolates of Mycobacterium abscessus.

Maurer FP, Castelberg C, Quiblier C, Böttger EC, Somoskövi A.

J Antimicrob Chemother. 2014 Jun;69(6):1559-63. doi: 10.1093/jac/dku007. Epub 2014 Feb 4.

33.

Close geographic association of human neoehrlichiosis and tick populations carrying "Candidatus Neoehrlichia mikurensis" in eastern Switzerland.

Maurer FP, Keller PM, Beuret C, Joha C, Achermann Y, Gubler J, Bircher D, Karrer U, Fehr J, Zimmerli L, Bloemberg GV.

J Clin Microbiol. 2013 Jan;51(1):169-76. doi: 10.1128/JCM.01955-12. Epub 2012 Oct 31.

34.

Acquisition of clarithromycin resistance mutations in the 23S rRNA gene of Mycobacterium abscessus in the presence of inducible erm(41).

Maurer FP, Rüegger V, Ritter C, Bloemberg GV, Böttger EC.

J Antimicrob Chemother. 2012 Nov;67(11):2606-11. doi: 10.1093/jac/dks279. Epub 2012 Jul 24.

Supplemental Content

Loading ...
Support Center